MJET is a fork of sjet, which was developed by siberas but is no longer actively maintained. MJET is maintained by the MOGWAI LABS team which also provided most of the original sjet codebase. MJET ...

A new AAV-based gene therapy successfully improved seizures, behavior, and brain activity in fragile X syndrome mice, paving the way for clinical development.